Anton J Bilchik, J Randolph Hecht. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AnimalsAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/adverse effectsBevacizumabChemotherapy, Adjuvant/adverse effectsColorectal Neoplasms/pathologyEvidence-Based MedicineHepatectomy/methodsLiver Neoplasms/drug therapyLiver Neoplasms/secondaryLiver Neoplasms/surgeryLiver Regeneration/drug effectsMicePerioperative CarePremedication/adverse effectsVascular Endothelial Growth Factor A/antagonists & inhibitors
Substances： See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedVascular Endothelial Growth Factor ABevacizumab
Year: 2008 PMID： 18398144 DOI： 10.1200/JCO.2007.15.6380
Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544